NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Kathleen A Farley
Pfizer Inc. - New York / United States
Others
AD Scientific Index ID: 4399392
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Kathleen A Farley's MOST POPULAR ARTICLES
1-)
Delineating the role of cooperativity in the design of potent PROTACs for BTKA Zorba, C Nguyen, Y Xu, J Starr, K Borzilleri, J Smith, H Zhu, KA Farley, ...Proceedings of the National Academy of Sciences 115 (31), E7285-E7292, 20182322018
2-)
A New Resistance Gene, linB, Conferring Resistance to Lincosamides by Nucleotidylation in Enterococcus faecium HM1025B Bozdogan, L Berrezouga, MS Kuo, DA Yurek, KA Farley, BJ Stockman, ...Antimicrobial Agents and Chemotherapy 43 (4), 925-929, 19992191999
3-)
Discovery of cytotoxic dolastatin 10 analogues with N-terminal modificationsA Maderna, M Doroski, C Subramanyam, A Porte, CA Leverett, ...Journal of medicinal chemistry 57 (24), 10527-10543, 20141152014
4-)
Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearanceAC Rand, SSF Leung, H Eng, CJ Rotter, R Sharma, AS Kalgutkar, ...MedChemComm 3 (10), 1282-1289, 20121432012
5-)
Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a toolM Shalaeva, G Caron, YA Abramov, TN O’Connell, MS Plummer, ...Journal of medicinal chemistry 56 (12), 4870-4879, 2013972013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept